Annelise Mery - Brossel

Annelise Mery-Brossel has been working in the field of Regulatory Affairs for over 20 years. Annelise began their career in 2000 as a Regulatory Affairs Intelligence at Pfizer, followed by a Regulatory Affairs Manager role at Baxter International Inc. from 2001-2011. Annelise then moved to LFB as a Senior Regulatory Affairs Manager and Responsable d'unité from 2011-2016. In 2016, they joined Onxeo S.A. as a Senior Regulatory Affairs Manager, before taking on the role of Director Regulatory Affairs at GenSight Biologics in 2018. Annelise currently serves as the Director Regulatory Affairs and Quality Assurance at Vivet Therapeutics since 2019.

Annelise Mery-Brossel has completed a DESS Developpement et enregistrement international des médicaments at Paris-Sud University (Paris XI) from 1999 to 2000 in the field of Affaires réglementaires. Annelise has also completed a Pharmacy degree at Paris-Sud University (Paris XI) from 1994 to 2000.